Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Oral, Maxillofacial and Reconstructive Surgery, Private Practice, Aiea, HI, USA. CLee555294@aol.com
Biochemical markers of bone metabolism have been used in medicine to evaluate and provide treatment to patients with metabolic bone diseases, such as osteoporosis. Serum cross-linked C-telopeptide of type I collagen is a marker of osteoclast activity and is used to assess the level of bone resorption. Recently, in oral and maxillofacial surgery, it was proposed that the levels of serum cross-linked C-telopeptide of type I collagen may predict the subsequent risk of developing osteonecrosis of the jaws after oral surgery procedures for patients taking oral bisphosphonates. The astute clinician must critically review the scientific literature and must decide if biochemical markers of bone resorption are of benefit in managing the oral surgery patient on bisphosphonates.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on